Table 2 Distribution of herpesviruses in leukemic patients (ALL or AML)
Viral infection | Patients N = 95 (%) | Patients with AML N = 43 (%) | Patients with ALL N = 52 (%) | P |
|---|---|---|---|---|
Single CMV | 21 (22.1) | 12 (27.9) | 9 (17.3) | 0.227 |
Single EBV | 3 (3.1) | – | 3 (5.8) | 0.248 |
Single HHV-6 | 5 (5.3) | 2 (4.6) | 3 (5.8) | 1.000 |
Single HHV-7 | 4 (4.2) | – | 4 (7.7) | 1.000 |
CMV + HHV-6 | 15 (15.8) | 5 (11.6) | 10 (19.2) | 0.401 |
CMV + HHV-7 | 5 (5.3) | 4 (9.3) | 1 (2) | 0.172 |
EBV + HHV-7 | 1(1.1) | – | 1 (2) | 1.000 |
CMV + HHV6 + HHV7 | 2(2.1) | 2 (4.6) | – | 0.202 |
CMV + EBV + HHV6 | 2(2.1) | 1 (2.3) | 1 (2) | 1.000 |
EBV + HHV6 + HHV7 | 1(1.1) | 1 (2.3) | – | 0.452 |
EBV + CMV + HHV7 | 1(1.1) | – | 1 (2) | 1.000 |
Negative for all | 35(36.8) | 16 (37.2) | 19 (36.5) | 1.000 |
Positive for 1 or more | 60(63.2) | 27 (62.8) | 33 (63.5) | 1.000 |